Get notified of page updates

Cancer treatment for people with MAP

Currently there are no cancer treatments approved specifically for people with MAP, however, clinical trials looking at new types of treatment may be available in the future. Colorectal cancers in people with MAP often have an acquired mutation called KRAS G12C, and there are clinical trials investigating new medications to treat colorectal cancers with this specific KRAS mutation. To learn more about standard of care treatment options for specific types of cancer, visit our section on Cancer Treatment by Cancer Type

Last updated February 13, 2022

Open Clinical Trials
Open Clinical Trials

The following studies are open to people with colorectal cancer with a KRAS G12C mutation. These mutations are particularly common in people with MAP. 

updated: 05/29/2023